RBC Capital Reaffirms Their Buy Rating on Stericycle (SRCL)

In a report issued on June 8, Sean Dodge from RBC Capital maintained a Buy rating on Stericycle (SRCLResearch Report), with a price target of $82.00. The company’s shares closed last Friday at $46.40, close to its 52-week low of $44.04.

According to TipRanks.com, Dodge is a 1-star analyst with an average return of -2.1% and a 44.5% success rate. Dodge covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, NextGen Healthcare, and Thorne HealthTech.

Stericycle has an analyst consensus of Hold, with a price target consensus of $61.00.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $75.09 and a one-year low of $44.04. Currently, Stericycle has an average volume of 509.4K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stericycle, Inc. engages in the provision of waste management services. It operates through the following segments: Domestic and Canada Regulated Waste and Compliance Services (RCS); International RCS; and Domestic CRS. The Domestic and Canada RCS segment manages medical and pharmaceutical waste disposal, hazardous wastes, and unused and expired inventory. The International RCS segment includes patient transport services. The Domestic Communication and Related Services segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns, and quality audits. The company was founded in March 1989 and is headquartered in Lake Forest, IL.

Read More on SRCL:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More